Differential protein analysis of spasomolytic polypeptide expressing metaplasia using laser capture microdissection and two-dimensional difference gel electrophoresis

Applied Immunohistochemistry and Molecular Morphology

Volumn 11, Issue 2, 2003, Pages 188-193

  Lee, Jeffrey R ^a,b   Baxter, Tammy M ^b   Yamaguchi, Hirokazu ^b   Wang, Timothy C ^c   Goldenring, James R ^a,b   Anderson, Mark G ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Proteomics; Spasmolytic polypeptide expressing metaplasia; Two dimensional difference gel electrophoresis

Indexed keywords

CYANINE DYE; SPASMOLYTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL POPULATION; HELICOBACTER FELIS; HELICOBACTER PYLORI; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LASER; METAPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; STOMACH ADENOCARCINOMA; STOMACH ANTRUM; STOMACH FUNDUS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 0037898953     PISSN: 15412016     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129039-200306000-00018     Document Type: Article

References (16)

1. Gygi SP, Rochon Y, Franza BR, et al. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999;19:1720-30.
2. Gygi SP, Corthals GL, Zhang Y, et al. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci U S A 2000;97:9390-5.
3. Zhou G, Li H, DeCamps D, et al. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Molecular and Cellular Proteomics 2002;1:117-24.
4. Gharbi S, Gaffney P, Yang A, et al. Evaluation of two dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Molecular and Cellular Proteomics 2002;1:91-8.
5. Wang TC, Goldenring JR, Dangler C, et al. C57BL/6 mice deficient in secretory phospholipase A2 show increased apoptosis and altered cellular differentiation during Helicobacter felis infection. Gastroenterology 1998;114:675-89.
6. Schmidt PH, Lee JR, Joshi V, et al. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest 1999;79:439-46.
7. Wong WM, Garcia SB, Poulson R, et al. Aberrant spasmolytic peptide (TTF2)-expressing cell lineage (SPEM), pseudopyloric metaplasia (PPM) and the response to gastric mucosal damage. Gastroenterology 1999;116:A525.
8. Whitehead R. Gastrointestinal and oesophageal pathology. Edinburgh: Churchill Livingstone, 1989:411.
9. Yamaguchi H, Goldenring JR, Kamanichi M, et al. Identification of spasmolytic polypeptide expressing metaplasia in remnant gastric cancer and surveillance postgastrectomy biopsies. Dig Dis Sci 2002;47:573-8.
10. Halldorsdottir AM, Jonasson JG, Oddsdottir M, et al. SP expressing metaplasia (SPEM) and early gastric cancer. Gastroenterology 2001;120:A745.
11. Yamaguchi H, Goldenring JR, Kamanichi M, et al. Association of spasmolytic polypeptide expressing metaplasia (SPEM) with carcinogen administration and oxyntic atrophy in rats. Lab Invest 2002;82:1045-52.
12. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.
13. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling Nature 2000;406:536-40.
14. Tonge R, Shaw J, Middleton B, et al. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001;1:377-96.
15. Emmert-Buck MR, Gillespie JW, Paweletz CP, et al. An approach to proteomic analysis of human tumors. Mol Carcinog 2000;27:158-65.
16. Ornstein DK, Gillespie JW, Paweletz CP, et al. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis. 2000;21:2235-42.